Precision Autophagy Directed by Receptor Regulators – Emerging Examples Within the TRIM Family Tomonori Kimura*, Michael Mandell and Vojo Deretic*

Total Page:16

File Type:pdf, Size:1020Kb

Precision Autophagy Directed by Receptor Regulators – Emerging Examples Within the TRIM Family Tomonori Kimura*, Michael Mandell and Vojo Deretic* © 2016. Published by The Company of Biologists Ltd | Journal of Cell Science (2016) 129, 881-891 doi:10.1242/jcs.163758 COMMENTARY Precision autophagy directed by receptor regulators – emerging examples within the TRIM family Tomonori Kimura*, Michael Mandell and Vojo Deretic* ABSTRACT A morphologically emblematic event during autophagy is the Selective autophagy entails cooperation between target recognition formation in the cytoplasm of the membranous organelles termed and assembly of the autophagic apparatus. Target recognition is autophagosomes; these are the executors of macro-autophagy conducted by receptors that often recognize tags, such as ubiquitin (hereafter referred to as autophagy) (Mizushima et al., 2011). and galectins, although examples of selective autophagy Autophagosomes are decorated in yeast with Atg8 and in mammals – independent of these tags are emerging. It is less known how with LC3B [one of six mammalian (m)Atg8 paralogs LC3A, MAP1LC3A MAP1LC3B receptors cooperate with the upstream autophagic regulators, beyond LC3B and LC3C (encoded by , and MAP1LC3C the well-characterized association of receptors with Atg8 or its , respectively) and GABARAP, GABARAPL1 and homologs, such as LC3B (encoded by MAP1LC3B), on autophagic GABARAPL2 (Mizushima et al., 2011; Weidberg et al., 2011)]. membranes. The molecular details of the emerging role in autophagy mAtg8 proteins are conjugated at their C-terminus to a lipid, of the family of proteins called TRIMs shed light on the coordination phosphatidylethanolamine (PtdEtn), which in turn mediates between cargo recognition and the assembly and activation of the association with the autophagic membrane (Kabeya et al., 2000). principal autophagy regulators. In their autophagy roles, TRIMs act Many other parts of the core autophagy machinery are well- both as receptors and as platforms (‘receptor regulators’) for the conserved from yeast to humans (Mizushima et al., 2011). In assembly of the core autophagy regulators, such as ULK1 and Beclin 1 mammals, the key autophagy factors (ATG) include ULK1 (one of in their activated state. As autophagic receptors, TRIMs can directly four mammalian paralogs of Atg1) (Chan et al., 2007; Kundu and recognize endogenous or exogenous targets, obviating a need for Thompson, 2008) and Beclin 1 (a paralog of yeast Atg6) (Liang intermediary autophagic tags, such as ubiquitin and galectins. The et al., 1999). These principal autophagy regulators are controlled by ′ receptor and regulatory features embodied within the same entity upstream serine and threonine (Ser/Thr) protein kinases 5 -AMP- allow TRIMs to govern cargo degradation in a highly exact process activated protein kinase (AMPK) and mammalian target of termed ‘precision autophagy’. rapamycin (mTOR) (Egan et al., 2011; Kim et al., 2011, 2013; Russell et al., 2013), as well as E3 ligases and ubiquitylation (Nazio KEY WORDS: Receptor regulators, TRIMs, Autophagy et al., 2013). Lipid kinases, most notably the class III phosphatidylinositol 3-kinase (PI3K) VPS34 (encoded by Introduction PIK3C3; which forms a complex with Beclin 1), co-activate Autophagy is a set of diverse processes, often classified as macro- autophagy by producing phosphatidylinositol 3-phosphate autophagy, micro-autophagy and chaperone-mediated autophagy, [PtdIns(3)P], a step that commits them to participating in which recognize and deliver endogenous cellular constituents or autophagosome formation (Petiot et al., 2000); however, the roles exogenous cargo to lysosomes for degradation (Mizushima et al., of other mono-phosphoinositides such as phosphatidylinositol 5- 2011). Autophagy can occur in bulk as a response to starvation, phosphate have recently been suggested (Vicinanza et al., 2015). whereby portions of the cytoplasm are auto-digested to meet the The protein kinases (ULK1), lipid kinases (Beclin-1–VPS34) and heightened biogenesis and energy needs of the cell (Rabinowitz and the LC3-conjugation system are all physically connected in their White, 2010; Galluzzi et al., 2014). Autophagy plays equally role in controlling autophagy. First, PtdIns(3)P is recognized by important roles in homeostasis, acting as a quality and quantity WD repeat domain phosphoinositide-interacting protein 2 (WIPI2, control process by removing protein aggregates (Rubinsztein et al., the mammalian Atg18), which interacts with ATG16L1 and forms 2012; Birgisdottir et al., 2013) and defunct or surplus organelles part of the LC3–PtdEtn conjugation system (Dooley et al., 2014). (Maejima et al., 2013; Randow and Youle, 2014), as well as Second, ATG16L1 associates with FIP200 (also known as invading microbes and endogenous and exogenous inflammatory RB1CC1), a component of the ULK1 complex system (Fujita agonists (Deretic et al., 2015). The degradation targets for et al., 2013; Gammoh et al., 2013; Nishimura et al., 2013; Dooley autophagy are not limited to cargo of the cytoplasmic origin, as et al., 2014). Autophagy is further coupled to the lysosomal systems. autophagy can also target nuclear components (Dou et al., 2015). This occurs through the effects on autophagy of members of the key The selectivity of autophagy (Fig. 1) has been a topic of continuing regulator of lysosomal biogenesis ‘microphthalmia/transcription interest; it has been established that a number of receptors can guide factor E’ (MiT/TFE) family (including transcription factor EB; autophagic machinery to targets, which are often earmarked for TFEB) (Settembre et al., 2011; Perera et al., 2015) and through autophagy with ubiquitin or galectins tags (Randow and Youle, SNAREs (Itakura et al., 2012), which enable the maturation of 2014; Stolz et al., 2014). autophagosomes into the autolysosome. Thus, all parts of the autophagy system are interconnected, thereby enabling spatial and temporal regulation of autophagy. Department of Molecular Genetics and Microbiology, University of New Mexico The homing of the autophagy machinery to intended targets Health Sciences Center, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA. through receptors is an area of intense study (Birgisdottir et al., *Authors for correspondence ([email protected]; [email protected]) 2013; Rogov et al., 2014; Khaminets et al., 2015). Frequently, Journal of Cell Science 881 COMMENTARY Journal of Cell Science (2016) 129, 881-891 doi:10.1242/jcs.163758 A Precision autophagy B Selective autophagy C Nonselective (bulk) group of mammalian proteins, additional receptors fit the SLR autophagy criteria. For instance, RPN10, an Arabidopsis receptor that mediates autophagic degradation of proteasome, binds to ubiquitin tags and Atg8s through its ubiquitin-interacting motif (UIM) domains ULK1 (Marshall et al., 2015). Furthermore, Toll-interacting protein Beclin 1 (TOLLIP) in mammals and Cue5 in yeast fit SLR criteria; Cue5 directly binds both to ubiquitin and to Atg8, whereas TOLLIP Direct target recognition Generic tag-based No known selectivity directly binds to ubiquitin and, in cellular extracts, to LC3 (Lu et al., Assembly of autophagy selectivity 2014). regulators and effectors Key The TRIM protein family Autophagic ULK1 Autophagy TRIMs were first recognized as a family (Reymond et al., 2001) Target or cargo LIR organelles Beclin 1 regulators based on their common tri-partite domain organization, typically Ubiquitin or galectin tag Receptor Receptor mAtg8s comprising an N-terminal RING domain, one or two B-box regulator domains and a coiled-coil domain, although they also have additional features, including a variety of C-terminal domains, Fig. 1. Precision autophagy. (A) Precision autophagy is a receptor-regulator- based form of autophagy. A receptor-regulator protein (such as members of inclusive of SPRY domains (Fig. 2A,B; Table S1). TRIMs are the TRIM family) has the ability to recognize targets directly, often without tags conserved in metazoans, and the number of genes encoding them such as ubiquitin or galectins, and assembles regulators and effectors of escalates in higher organisms (Sardiello et al., 2008; Boudinot et al., autophagy to mediate precision (highly selective) autophagy. (B) Conventional 2011); 82 TRIM genes (excluding the pseudogenes) have been selective autophagy is mediated by autophagic receptors that recognize identified in humans (Table S1). targets through generic tags, such as ubiquitin or galectins, while also binding TRIMs are involved in a variety of seemingly disparate cellular mammalian (m)Atg8 proteins that connect them to autophagic membranes. (C) Nonselective (bulk) autophagy sequesters mixtures of cytoplasmic processes (Table S1); these include cell survival and death components, including cytosol. (Grignani et al., 1993), cell cycle and differentiation (Wang et al., 1998), metabolic states (Skurat et al., 2002), cell membrane repair (Cai et al., 2009), synaptic vesicle exocytosis (Li et al., 2001), targets exhibit ubiquitin or galectin marks, although this does not senescence (Pearson et al., 2000), stem cell pluripotency (Sato et al., appear to be an absolute requirement (Khaminets et al., 2015). 2012) and erythrocyte differentiation (Blaybel et al., 2008; Barde Furthermore, the number of proteinaceous, membranous and et al., 2013), as well as the control of viral, bacterial and fungal complex targets for selective autophagy is rapidly increasing. This infections (Nisole et al., 2005; Rakebrandt et al., 2014; Cao et al., raises an important question: are the number of receptors and the 2015). These and additional roles are linked to a variety of health principles
Recommended publications
  • Since January 2020 Elsevier Has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19
    Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. Journal Pre-proof Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance Renuka Choudhary, Anil K. Sharma, Renuka Choudhary PII: S2052-2975(20)30036-6 DOI: https://doi.org/10.1016/j.nmni.2020.100684 Reference: NMNI 100684 To appear in: New Microbes and New Infections Received Date: 12 April 2020 Revised Date: 15 April 2020 Accepted Date: 16 April 2020 Please cite this article as: Choudhary R, Sharma AK, Choudhary R, Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance, New Microbes and New Infections, https://doi.org/10.1016/j.nmni.2020.100684. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.
    [Show full text]
  • Autophagy: from Basic Science to Clinical Application
    nature publishing group REVIEW See COMMENTARY page XX Autophagy: from basic science to clinical application J Va n L i m b e r g e n 1 , 2 , 3 , C S t e v e n s 4 , E R N i m m o 1 , D C W i l s o n 2 , 3 a n d J S a t s a n g i 1 Autophagy is a cellular pathway involved in protein and organelle degradation, which is likely to represent an innate adaptation to starvation. In times of nutrient deficiency, the cell can self-digest and recycle some nonessential components through nonselective autophagy, thus sustaining minimal growth requirements until a food source becomes available. Over recent years, autophagy has been implicated in an increasing number of clinical scenarios, notably infectious diseases, cancer, neurodegenerative diseases, and autoimmunity. The recent identification of the importance of autophagy genes in the genetic susceptibility to Crohn ’ s disease suggests that a selective autophagic response may play a crucial role in the pathogenesis of common complex immune-mediated diseases. In this review, we discuss the autophagic mechanisms, their molecular regulation, and summarize their clinical relevance. This progress has led to great interest in the therapeutic potential of manipulation of both selective and nonselective autophagy in established disease. INTRODUCTION The ability to adapt to environmental change is essential for sur- Autophagy encompasses several distinct processes involving vival. This is true for the organism as a whole and for individual the delivery of portions of the cytoplasm to the lysosome for cells alike.
    [Show full text]
  • Tamoxifen Erythroid Toxicity Revealed by Studying the Role of Nuclear
    COMMENT as in Santana-Codina et al.1 Briefly, 12-week old Sv129/J Tamoxifen erythroid toxicity revealed by studying Ncoa4-ko and wild-type littermates received 200 mg/kg the role of nuclear receptor co-activator 4 in tamoxifen via oral gavage daily for five consecutive days erythropoiesis (day 0-4) and complete blood count was obtained at days 0, 4, 11 and 21. We chose mice on Sv129/J background We read with great interest the paper recently pub- that, unlike C57BL/6 Ncoa4-ko animals,4 do not show lished by Santana-Codina et al.1 about the cell anemia or alterations of iron parameters but only mild autonomous and non-autonomous role of nuclear recep- microcytosis (Figure 1 and Nai et al., 2019, manuscript in tor co-activator 4 (NCOA4). NCOA4 is a cargo receptor preparation). At day 4, only Ncoa4-ko mice showed a sta- that, in conditions of iron deficiency, promotes fer- tistically significant decrease in red blood cell (RBC) ritinophagy to release iron from ferritin.2,3 Inactivation of count, and hematocrit (Hct) and hemoglobin (Hb) levels. Ncoa4 in C57BL/6 mice causes mild microcytic anemia and increases the susceptibility to iron-deficiency anemia At day 11, also wild-type mice showed a reduction in due to iron being trapped in ferritin in several organs.3,4 To RBC count and decreased Hb and Hct, although for the formally prove the role of Ncoa4 inactivation on erythro- latter two parameters levels were higher than those of poiesis, a tamoxifen-inducible CRE-dependent Ncoa4-ko mice.
    [Show full text]
  • Autophagy Patterns and Prognosis in Uveal Melanomas
    Modern Pathology (2011) 24, 1036–1045 1036 & 2011 USCAP, Inc. All rights reserved 0893-3952/11 $32.00 Autophagy patterns and prognosis in uveal melanomas Alexandra N Giatromanolaki1, Georgios St Charitoudis2, Nikolaos E Bechrakis3, Vassilios P Kozobolis4, Michael I Koukourakis5, Michael H Foerster2 and Efthimios L Sivridis1 1Department of Pathology, Democritus University of Thrace Medical School, Alexandroupolis, Greece; 2Department of Ophthalmology, Charite´ Medical University, Campus Benjamin Franklin, Berlin, Germany; 3Department of Ophthalmology, University of Innsbruck Medical School, Innsbruck, Austria; 4Department of Ophthalmology, Democritus University of Thrace Medical School, Alexandroupolis, Greece and 5Department of Radiotherapy/Oncology, Democritus University of Thrace Medical School, Alexandroupolis, Greece Autophagy is a self-degradation mechanism by which cells recycle their own cytoplasmic constituents. It has been claimed that, under certain conditions, such a process may be associated with tumor progression. In this study, the autophagic activity was investigated in a series of 99 uveal melanomas after immunohistochemical staining for the autophagy-associated proteins MAP1LC3A and BECN1, most commonly known as LC3A and Beclin 1, respectively. These were assessed in parallel with the hypoxia-inducible factor 1a (HIF1A) and its downstream protein lactate dehydrogenase 5 (composed by five LDHA subunits). Increased autophagic reactivity, detected by MAP1LC3A or BECN1, was associated with intense pigmentation and tumor hypoxia. Uveal melanomas with extensive overexpression of BECN1 or those with underexpression of this protein were associated with the worst prognosis, but the former manifested metastases much earlier than the latter; only 58% of patients with extensive BECN1 overexpression were alive at 4 years, compared with 80% of patients with underexpressed patterns.
    [Show full text]
  • Dr. Mary Ann Osley – Professor: Dr. Osley's Laboratory Is Focused on The
    Dr. Vojo Deretic – Chair: Dr. Dr. Mary Ann Osley – Dr. Robert Rubin– Professor: Dr. Michelle Ozbun – Dr. David Peabody – Deretic's main contributions to Professor: Dr. Osley’s Dr. Rubin’s lab explores T cell Professor: Dr. Ozbun’s lab Professor: Dr. Peabody was science come from studies by laboratory is focused on the tolerance and autoimmunity, T studies the cellular and viral trained at Stanford University his team on the role of role of chromatin in gene cell development in the mechanisms that regulate the in the laboratory of Paul Berg autophagy in infection and expression, DNA replication, thymus, systemic and drug- life cycles of papillomaviruses (Nobel Prize, 1980) and has (PVs), aiming to understand immunity. Autophagy, a cytoplasmic and DNA repair as cells enter induced lupus, & autoantibody been associated with UNM the delicate virus-cell interactions that can since 1984. For a number of years his pathway for the removal of damaged or and exit quiescence. Her research uses biosensors. Dr. Rubin’s laboratory also become unbalanced, leading to group studied RNA viruses of bacteria as surplus organelles, has been previously budding yeast, Saccharomyces cerevisiae, studies the cellular and molecular basis for malignancies. Three areas of research model systems to understand gene implicated in cancer, neurodegeneration, to study these cellular processes. the capacity of lupus-inducing drugs to interests are understanding: a) strategies development, and aging. Dr. Deretic's disrupt central T cell tolerance. regulation. In recent years his group has for PV infection and persistence; b) PV group is one of those that made the focused on adapting the virus-like particles and host interactions; c) the mechanisms discovery that autophagic degradation is a of these bacteriophages as platforms for of HPV-induced malignant transformation.
    [Show full text]
  • Deficiency in Class III PI3-Kinase Confers Postnatal Lethality with IBD
    ARTICLE DOI: 10.1038/s41467-018-05105-8 OPEN Deficiency in class III PI3-kinase confers postnatal lethality with IBD-like features in zebrafish Shaoyang Zhao1,2,3, Jianhong Xia2,3, Xiuhua Wu2,3, Leilei Zhang2,3, Pengtao Wang2,3, Haiyun Wang2,3, Heying Li2, Xiaoshan Wang 2, Yan Chen 2, Jean Agnetti2, Yinxiong Li 2, Duanqing Pei2,3 & Xiaodong Shu2,3 The class III PI3-kinase (PIK3C3) is an enzyme responsible for the generation of phospha- tidylinositol 3-phosphate (PI3P), a critical component of vesicular membrane. Here, we report 1234567890():,; that PIK3C3 deficiency in zebrafish results in intestinal injury and inflammation. In pik3c3 mutants, gut tube forms but fails to be maintained. Gene expression analysis reveals that barrier-function-related inflammatory bowel disease (IBD) susceptibility genes (e-cadherin, hnf4a, ttc7a) are suppressed, while inflammatory response genes are stimulated in the mutants. Histological analysis shows neutrophil infiltration into mutant intestinal epithelium and the clearance of gut microbiota. Yet, gut microorganisms appear dispensable as mutants cultured under germ-free condition have similar intestinal defects. Mechanistically, we show that PIK3C3 deficiency suppresses the formation of PI3P and disrupts the polarized dis- tribution of cell-junction proteins in intestinal epithelial cells. These results not only reveal a role of PIK3C3 in gut homeostasis, but also provide a zebrafish IBD model. 1 School of Life Sciences, University of Science and Technology of China, 230027 Hefei, Anhui, China. 2 CAS Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health-Guangzhou Medical University Joint School of Biological Sciences, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, 510530 Guangzhou, China.
    [Show full text]
  • Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1
    www.nature.com/scientificreports OPEN Reversible Human Immunodefciency Virus Type-1 Latency in Primary Human Received: 11 January 2018 Accepted: 13 August 2018 Monocyte-Derived Macrophages Published: xx xx xxxx Induced by Sustained M1 Polarization Francesca Graziano1,4, Giulia Aimola1, Greta Forlani 2, Filippo Turrini 1, Roberto S. Accolla2, Elisa Vicenzi1 & Guido Poli1,3 We have reported that short-term stimulation of primary human monocyte-derived macrophages (MDM) with interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α), i.e. M1 polarization, leads to a signifcant containment of virus replication. Here we show that M1-MDM restimulation with these cytokines 7 days after infection (M12 MDM) promoted an increased restriction of HIV-1 replication characterized by very low levels of virus production near to undetectable levels. In comparison to control and M1-MDM that were not restimulated, M12 MDM showed a stronger reduction of both total and integrated HIV DNA as well as of viral mRNA expression. M12 MDM were characterized by an upregulated expression of restriction factors acting at the level of reverse transcription (RT), including apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A (APOBEC3A) and APOBEC3G, but not SAM domain and HD domain-containing protein 1 (SAMHD1). M12 MDM also showed an increased expression of Class II Transactivator (CIITA) and Tripartite Motif22 (TRIM22), two negative regulators of proviral transcription, whereas expression and phosphorylation of transcriptional inducers of HIV-1, such as nuclear factor kB (NF-kB) and signal transducer and activator of transcription 1 (STAT1), were not impaired in these cells. The almost quiescent state of the infection in M12 MDM was promptly reversed by coculture with mitogen-stimulated leukocytes or cell incubation with their fltered culture supernatant.
    [Show full text]
  • NCOA4 Maintains Murine Erythropoiesis Via Cell Autonomous and Non-Autonomous Mechanisms
    Red Cell Biology & its Disorders SUPPLEMENTARY APPENDIX NCOA4 maintains murine erythropoiesis via cell autonomous and non-autonomous mechanisms Naiara Santana-Codina,1,* Sebastian Gableske,1,* Maria Quiles del Rey,1 Beata Małachowska,2,3 Mark P. Jedrychowski,1,4 Douglas E. Biancur,1 Paul J. Schmidt,5 Mark D. Fleming,5 Wojciech Fendler,1,2 J. Wade Harper,4,# Alec C. Kimmelman6,# and Joseph D. Mancias1 1Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; 2De- partment of Biostatistics and Translational Medicine, Medical University of Lodz, Poland; 3Postgraduate School of Molecular Medicine, Medical University of Warsaw, Poland; 4Department of Cell Biology, Harvard Medical School, Boston, MA, USA; 5Department of Pathology, Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA and 6Department of Radiation Oncology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA * These authors contributed equally to this work ©2019 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2018.204123 Received: August 10, 2018. Accepted: January 9, 2019. Pre-published: January 10, 2019. Correspondence: JOSEPH D. MANCIAS - [email protected] SUPPLEMENTARY INFORMATION SUPPLEMENTAL EXPERIMENTAL PROCEDURES Cell culture. Cells were cultured in a humidified incubator at 37°C and 5% carbon dioxide (CO2). HEK-293T and K562 cell lines were obtained from the American Type Culture Collection (ATCC, Manassas, Virginia) and tested for mycoplasma contamination by PCR. Cells were grown in DMEM (HEK-293T, Life Technologies, 11965) or IMDM (K562, Thermo Fisher 12440053) with 10% FBS and 1% Pen/Strep (Life Technologies 15140).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Clinical and Molecular Relevance of Genetic Variants in the Non-Coding
    Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia by Dimitrios Papaioannou, Hatice G. Ozer, Deedra Nicolet, Amog P. Urs, Tobias Herold, Krzysztof Mrózek, Aarif M.N. Batcha, Klaus H. Metzeler, Ayse S. Yilmaz, Stefano Volinia, Marius Bill, Jessica Kohlschmidt, Maciej Pietrzak, Christopher J. Walker, Andrew J. Carroll, Jan Braess, Bayard L. Powell, Ann-Kathrin Eisfeld, Geoffrey L. Uy, Eunice S. Wang, Jonathan E. Kolitz, Richard M. Stone, Wolfgang Hiddemann, John Byrd, Clara D. Bloomfield, and Ramiro Garzon Haematologica 2021 [Epub ahead of print] Citation: Dimitrios Papaioannou, Hatice G. Ozer, Deedra Nicolet, Amog P. Urs, Tobias Herold, Krzysztof Mrózek, Aarif M.N. Batcha, Klaus H. Metzeler, Ayse S. Yilmaz, Stefano Volinia, Marius Bill, Jessica Kohlschmidt, Maciej Pietrzak, Christopher J. Walker, Andrew J. Carroll, Jan Braess, Bayard L. Powell, Ann-Kathrin Eisfeld, Geoffrey L. Uy, Eunice S. Wang, Jonathan E. Kolitz, Richard M. Stone, Wolfgang Hiddemann, John Byrd, Clara D. Bloomfield, and Ramiro Garzon. Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia. Haematologica. 2021; 106:xxx doi:10.3324/haematol.2021.266643 Publisher's Disclaimer. E-publishing ahead of print is increasingly important for the rapid dissemination of science. Haematologica is, therefore, E-publishing PDF files of an early version of manuscripts that have completed a regular peer review and have been accepted for publication. E-publishing of this PDF file has been approved by the authors. After having E-published Ahead of Print, manuscripts will then undergo technical and English editing, typesetting, proof correction and be presented for the authors' final approval; the final version of the manuscript will then appear in print on a regular issue of the journal.
    [Show full text]
  • Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights Into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle
    animals Article Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle Masoumeh Naserkheil 1 , Abolfazl Bahrami 1 , Deukhwan Lee 2,* and Hossein Mehrban 3 1 Department of Animal Science, University College of Agriculture and Natural Resources, University of Tehran, Karaj 77871-31587, Iran; [email protected] (M.N.); [email protected] (A.B.) 2 Department of Animal Life and Environment Sciences, Hankyong National University, Jungang-ro 327, Anseong-si, Gyeonggi-do 17579, Korea 3 Department of Animal Science, Shahrekord University, Shahrekord 88186-34141, Iran; [email protected] * Correspondence: [email protected]; Tel.: +82-31-670-5091 Received: 25 August 2020; Accepted: 6 October 2020; Published: 9 October 2020 Simple Summary: Hanwoo is an indigenous cattle breed in Korea and popular for meat production owing to its rapid growth and high-quality meat. Its yearling weight and carcass traits (backfat thickness, carcass weight, eye muscle area, and marbling score) are economically important for the selection of young and proven bulls. In recent decades, the advent of high throughput genotyping technologies has made it possible to perform genome-wide association studies (GWAS) for the detection of genomic regions associated with traits of economic interest in different species. In this study, we conducted a weighted single-step genome-wide association study which combines all genotypes, phenotypes and pedigree data in one step (ssGBLUP). It allows for the use of all SNPs simultaneously along with all phenotypes from genotyped and ungenotyped animals. Our results revealed 33 relevant genomic regions related to the traits of interest.
    [Show full text]
  • MAP1LC3 Antibody Cat
    MAP1LC3 Antibody Cat. No.: 7951 MAP1LC3 Antibody Immunohistochemistry of MAP1LC3 in rat brain tissue with MAP1LC3 antibody at 5 μg/ml. Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human, Mouse, Rat HOMOLOGY: Predicted species reactivity based on immunogen sequence: Bovine: (100%) MAP1LC3 antibody was raised against a 12 amino acid peptide near the center of human MAP1LC3A. IMMUNOGEN: The immunogen is located within amino acids 20 - 70 of MAP1LC3. TESTED APPLICATIONS: ELISA, IHC-P, WB September 29, 2021 1 https://www.prosci-inc.com/map1lc3-antibody-7951.html MAP1LC3 antibody can be used for detection of MAP1LC3 by Western blot at 0.5 - 1 μg/ml. Antibody can also be used for Immunohistochemistry starting at 5 μg/mL. APPLICATIONS: Antibody validated: Western Blot in human samples and Immunohistochemistry in rat samples. All other applications and species not yet tested. MAP1LC3 antibody is human, mouse and rat reactive. Multiple isoforms MAP1LC3 are SPECIFICITY: known to exist. MAP1LC3 antibody is predicted to detect MAP1LC3A, MAP1LC3B, and MAP1LC3C. POSITIVE CONTROL: 1) Cat. No. 1303 - Human Brain Tissue Lysate Predicted: 13 kDa PREDICTED MOLECULAR WEIGHT: Observed: 18 kDa Properties PURIFICATION: MAP1LC3 antibody is affinity chromatography purified via peptide column. CLONALITY: Polyclonal ISOTYPE: IgG CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: MAP1LC3 antibody is supplied in PBS containing 0.02% sodium azide. CONCENTRATION: 1 mg/mL MAP1LC3 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one STORAGE CONDITIONS: year. Additional Info OFFICIAL SYMBOL: MAP1LC3A MAP1LC3 Antibody: LC3, LC3A, ATG8E, MAP1ALC3, MAP1BLC3Autophagy-related protein ALTERNATE NAMES: LC3 A ACCESSION NO.: NP_115903 PROTEIN GI NO.: 14210522 GENE ID: 84557 USER NOTE: Optimal dilutions for each application to be determined by the researcher.
    [Show full text]